We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
100 result(s) found, displaying 31 to 40
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Australian public assessment report (AusPar)New AusPAR for VEKLURY (remdesivir ) for the treatment of coronavirus disease 2019 in paediatric and adult patients.
-
Prescription medicine registrationActive ingredients: remdesivir.
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Cancellation by sponsorRequested by Gilead Sciences Pty Ltd
-
Australian public assessment report (AusPar)New AusPAR for Trodelvy (sacituzumab govitecan) for the treatment of breast cancer.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VEKLURY remdesivir 100 mg powder for injection vial.
-
-
-